Rosanne Dunn
Direttore Tecnico/Scientifico/R&S presso HaemaLogiX Pty Ltd.
Provenienza dei contatti di primo grado di Rosanne Dunn
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
HaemaLogiX Pty Ltd.
 HaemaLogiX Pty Ltd. BiotechnologyHealth Technology HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015.
5
| Holding Company | Biotechnology | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Rosanne Dunn tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| KAZIA THERAPEUTICS LIMITED | Pharmaceuticals: Major | Chairman | |
| IKARIA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Otago | College/University | Graduate Degree | |
| PHARMING GROUP N.V. | Pharmaceuticals: Major | Sales & Marketing | |
| The University of New South Wales | College/University | Undergraduate Degree | |
| Macquarie University | College/University | Graduate Degree | |
| The University of Sydney | College/University | Graduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
| University of Warwick | College/University | Masters Business Admin | |
| The University of Western Australia | College/University | Undergraduate Degree | |
| Massey University | College/University | Undergraduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
Eli Lilly Japan KK
 Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The company is based in Kobe, Japan. | Pharmaceuticals: Major | President | |
Minomic International Ltd.
 Minomic International Ltd. BiotechnologyHealth Technology Minomic International Ltd. develops diagnostic and imaging products for prostate cancer and diabetes. Its MiCheck test detects a protein that is present on cancer cells by using blood sample. The company was founded in 1974 and is headquartered in Sydney, Australia. | Biotechnology | Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Merk Sharp & Dohme (Holdings) Pty Ltd.
 Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Merk Sharp & Dohme (Holdings) Pty Ltd. develops, manufactures and markets drug therapies. The company was founded in 1958 and is headquartered in Macquarie Park, Australia. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Dunedin School of Medicine | College/University | Doctorate Degree | |
| Sanofi-Aventis Healthcare Pty Ltd. | Corporate Officer/Principal | ||
| RACE ONCOLOGY LIMITED | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Pharmaceuticals: Major | Director/Board Member | |
| Biosynergy Partners LLC | Corporate Officer/Principal | ||
| TEMPEST THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Ceramedix Holdings LLC | Director/Board Member | ||
| Daewoong-Lilly Pharmaceutical Co. | Corporate Officer/Principal | ||
Eli Lilly Australia Pty Ltd.
 Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly Australia Pty Ltd. manufactures and supplies pharmaceutical products. It develops medicines for diabetes, cancer, immunology, and pain. The company was founded in 1960 and is headquartered in West Ryde, Australia. | Pharmaceuticals: Major | Chairman |
Statistiche
Distribuzione geografica
| Stati Uniti | 18 |
| Australia | 13 |
| Regno Unito | 5 |
| Nuova-Zelanda | 4 |
| Giappone | 3 |
Settori
| Health Technology | 22 |
| Consumer Services | 12 |
| Finance | 3 |
| Commercial Services | 2 |
| Miscellaneous | 2 |
Posizioni
| Director/Board Member | 17 |
| Corporate Officer/Principal | 11 |
| Chairman | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 4 |
Contatti più connessi
| Insiders | |
|---|---|
| Geoffrey Nichol | 14 |
| John Cullity | 13 |
| Bryce D. Carmine | 8 |
| Damian Clarke-Bruce | 6 |
| Alan Liddle | 5 |
- Borsa valori
- Insiders
- Rosanne Dunn
- Connessioni Società
